BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative Employers
  Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Shire Human Genetic Therapies 

Shire Way

Lexington  Massachusetts  02421  U.S.A.
Phone: 617-349-0200 Fax: 617-613-4004


SEARCH JOBS

Founded in 1986, Shire is a fast-growing global specialty biopharmaceutical company with 2009 revenues of more than $3 billion and over 3,500 employees worldwide. A global leader working to meet the needs of the specialist physician and the patients they serve, Shire today has a presence in 23 countries and medicines available in nearly 40 countries. We focus on the therapeutic areas of attention deficit hyperactivity disorder (ADHD), gastrointestinal (GI), and genetic disorders. Encouraging our employees to be innovative, to take measured risks, and to act on the needs of our patients help define Shire and our people.

Our operation is structured in two complementary businesses – Human Genetic Therapies (HGT), and Specialty Pharmaceuticals – that are each supported by various corporate functions. With a major presence in Massachusetts, our HGT team specializes in researching, developing, and commercializing therapies for the treatment of rare genetic diseases caused by protein deficiencies. Shire’s Specialty Pharmaceuticals team, with major operations in Pennsylvania, is made up currently of three business units – ADHD, GI, and Emerging Products. This team also oversees many other marketed medicines approved to help people around the world.

By encouraging trust and openness in all we do, Shire has evolved through strategic acquisitions into a unique, nimble organization that is able to act quickly and take advantage of business opportunities as they arise. Through a culture that allows all employees to potentially impact and shape our business, Shire distinguishes itself from other biopharma organizations. Working as a team, our employees strive to continually achieve our purpose of enabling people with life-altering conditions to lead better lives.

We are always looking for talented people to join the Shire team. To learn more about Shire, visit www.shire.com. For more information on career opportunities with Shire, please visit: www.TimeToBeBrave.com.

Shire ... To be as brave as the people we help.



 Key Statistics


Email:
Ownership: Subsidiary

Web Site: Shire Human Genetic Therapies
Employees:
Symbol: SHPGY
 




Segment
Drug Delivery





 Company News
Frederic Chereau Joins Shire Human Genetic Therapies (SHPGY) to Lead Angioedema Franchise 9/26/2012 9:55:05 AM    More...
Massachusetts Sees $2 Billion Construction Boom from the Biopharma Industry Including Shire Human Genetic Therapies (SHPGY) and Pfizer Inc. (PFE) 4/6/2012 7:50:51 AM    More...
Abbott Laboratories (ABT), Bristol-Myers Squibb Company (BMY) and Shire Human Genetic Therapies (SHPGY) are Inaugural Partners for Worcester Polytechnic Institute/Gateway Park Biomanufacturing Education and Training Center 6/9/2011 10:37:23 AM    More...
Paladin Labs Inc. (CC:PLB) Expands Distribution Agreement with Shire Human Genetic Therapies (SHPGY) HGT to Include ELAPRASE(TM) (Idursulfase) 8/9/2007 9:37:37 AM    More...
Shire Human Genetic Therapies (SHPGY) Signs Exclusive Marketing and Distribution Deal With Samaritan Pharmaceuticals, Inc. (SPHC) to Launch REPLAGAL for Fabry Disease in Greece and Cyprus 5/22/2007 12:16:57 PM    More...